These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35920774)

  • 1. Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study.
    Bournia VK; Fragoulis GE; Mitrou P; Mathioudakis K; Tsolakidis A; Konstantonis G; Tseti I; Vourli G; Tektonidou MG; Paraskevis D; Sfikakis PP
    Rheumatology (Oxford); 2023 Mar; 62(3):1047-1056. PubMed ID: 35920774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019.
    Bournia VK; Fragoulis GE; Mitrou P; Mathioudakis K; Tsolakidis A; Konstantonis G; Vourli G; Paraskevis D; Tektonidou MG; Sfikakis PP
    RMD Open; 2021 Nov; 7(3):. PubMed ID: 34728554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study.
    Bournia VK; Fragoulis GE; Mitrou P; Mathioudakis K; Konstantonis G; Tektonidou MG; Tsolakidis A; Paraskevis D; Sfikakis PP
    Rheumatology (Oxford); 2024 Apr; 63(4):1130-1138. PubMed ID: 37467059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
    Park EH; Strand V; Oh YJ; Song YW; Lee EB
    Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
    Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
    Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
    Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
    J Rheumatol; 2022 May; 49(5):523-530. PubMed ID: 35105713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Myocardial Infarction in Autoimmune Rheumatologic Disease: A Nationwide Analysis of Clinical Outcomes and Predictors of Management Strategy.
    Mohamed MO; Roddy E; Ya'qoub L; Myint PK; Al Alasnag M; Alraies C; Clarson L; Helliwell T; Mallen C; Fischman D; Al Shaibi K; Abhishek A; Mamas MA
    Mayo Clin Proc; 2021 Feb; 96(2):388-399. PubMed ID: 33248709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark.
    Cordtz R; Lindhardsen J; Soussi BG; Vela J; Uhrenholt L; Westermann R; Kristensen S; Nielsen H; Torp-Pedersen C; Dreyer L
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI59-SI67. PubMed ID: 33369663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
    Martinez SC; Mohamed M; Potts J; Abhishek A; Roddy E; Savage M; Bharadwaj A; Kwok CS; Bagur R; Mamas MA
    Rheumatology (Oxford); 2020 Sep; 59(9):2512-2522. PubMed ID: 31990337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases.
    Aaramaa HK; Mars N; Helminen M; Kerola AM; Palomäki A; Eklund KK; Gracia-Tabuenca J; Sinisalo J; FinnGen ; Isomäki P
    Semin Arthritis Rheum; 2024 Apr; 65():152382. PubMed ID: 38308930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
    Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post COVID-19 hospitalizations in patients with chronic inflammatory diseases - A nationwide cohort study.
    Nørgård BM; Zegers FD; Nielsen J; Kjeldsen J
    J Autoimmun; 2021 Dec; 125():102739. PubMed ID: 34757259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis.
    Dave AJ; Fiorentino D; Lingala B; Krishnan E; Chung L
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):323-7. PubMed ID: 24022876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study.
    Hsu CY; Ko CH; Wang JL; Hsu TC; Lin CY
    Arthritis Res Ther; 2019 Oct; 21(1):211. PubMed ID: 31604447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
    Chen HH; Chao WC; Liao TL; Lin CH; Chen DY
    PLoS One; 2018; 13(7):e0201340. PubMed ID: 30048527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis.
    Wang P; Ni J; Chu YY; Chen QQ; Wu GC; Fang Y; Chen C; Zhang RD; Jiang LQ; Zhao Y; Fang X; He J; Wang DG; Wang GH; Pan HF
    Biomed Pharmacother; 2022 Jun; 150():112997. PubMed ID: 35486976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.
    Hsu HC; Chang YS; Hou TY; Chen LF; Hu LF; Lin TM; Chiou CS; Tsai KL; Lin SH; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
    Clin Rheumatol; 2021 Sep; 40(9):3755-3763. PubMed ID: 33646447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Employment across chronic inflammatory rheumatic diseases and comparison with the general population.
    Mau W; Listing J; Huscher D; Zeidler H; Zink A
    J Rheumatol; 2005 Apr; 32(4):721-8. PubMed ID: 15801031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.
    Tsirves GK; Voulgari PV; Pelechas E; Asimakopoulos AD; Drosos AA
    Eur Arch Otorhinolaryngol; 2019 Sep; 276(9):2419-2426. PubMed ID: 31175453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.